Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Rise of NMSCs Among Hispanics, Asians Noted

Dermatol Surg; 2016 May; Loh, Ortiz, et al

Publish date:: May 25, 2016

The rise of nonmelanoma skin cancers in Hispanics and Asians, especially in women, is cause for concern given that they are the fastest growing ethnic populations in the US, a recent study noted. Researchers conducted a 5-year retrospective chart review using data from Hispanic, Asian, and white populations at University of California San Diego Dermatologic and Mohs Micrographic Surgery Center. They found:

• 4,029 NMSC cases, 3,881 (96.3%) were in whites, 115 (2.9%) were in Hispanics, and 33 (0.8%) were in Asians.

• Most cases in whites occurred in men, whereas the gender ratio was reversed for Hispanics and Asians.

• Hispanics had significantly more cases occurring in the central part of the face.

Citation: Loh TY, Ortiz A, Goldenberg A, Brian Jiang SI. Prevalence and clinical characteristics of nonmelanoma skin cancers among Hispanic and Asian patients compared with white patients in the United States: A 5-year, single-institution retrospective review. Dermatol Surg. 2016;42(5):639-45. doi:10.1097/DSS.0000000000000694.

This Week's Must Reads

Osteoporosis prevalence in PsA similar to general population,

Swedish registry study finds atopic dermatitis significantly associated with autoimmune diseases,

More severe AD correlates with worse sleep health and attention problems in children,

Shortcomings identified in study of acne videos on TikTok,

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Must Reads in Melanoma

Phase 1 study: Beta-blocker may improve melanoma treatment response,

‘Impressive’ results with neoadjuvant T-VEC in advanced melanoma,

Immune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggest,

Neoadjuvant immunotherapy combo produces high response rate in melanoma,

Vaccine regimen boosts immune response in malignant melanoma,